Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy
Angewandte Chemie International Edition · 04.03.2024 · 63 (10)
DOI: 10.1002/anie.202318530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 23.01.2024. Verfasst von Jianping Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and …. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National University of Singapore, National Medical Research Council, Singapore Ministry of Education.
Abstract (Originalsprache)
Dendritic cell (DC) maturation and antigen presentation are key factors for successful vaccine‐based cancer immunotherapy. This study developed manganese‐based layered double hydroxide (Mn‐LDH) nanoparticles as a self‐adjuvanted vaccine carrier that not only promoted DC maturation through synergistically depleting endogenous glutathione (GSH) and activating STING signaling pathway, but also facilitated the delivery of model antigen ovalbumin (OVA) into lymph nodes and subsequent antigen presentation in DCs. Significant therapeutic‐prophylactic efficacy of the OVA‐loaded Mn‐LDH (OVA/Mn‐LDH) nanovaccine was determined by the tumor growth inhibition in the mice bearing B16‐OVA tumor. Our results showed that the OVA/Mn‐LDH nanoparticles could be a potent delivery system for cancer vaccine development without the need of adjuvant. Therefore, the combination of GSH exhaustion and STING pathway activation might be an advisable approach for promoting DC maturation and antigen presentation, finally improving cancer vaccine efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
- School of Biomedical Engineering, Southern Medical of University, Guangzhou, Guangdong, 510515, P. R. China.
- CAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, Jiangsu, 215123, P. R. China.
- State Key Laboratory of Biochemical Engineering Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
- Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
ORCID-Profile: Xiaoyuan Chen
Förderung
- National University of Singapore
- National Medical Research Council
- Singapore Ministry of Education
- National Research Foundation
Zitieren
APA
Liu, J., Zhang, Y., Yang, B., Jia, Y., Liu, R. T., Ding, L., Shen, Z., & Chen, X. (2024). Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy. Angewandte Chemie International Edition, 63(10). https://doi.org/10.1002/anie.202318530
Vancouver
Liu J, Zhang Y, Yang B, Jia Y, Liu RT, Ding L, et al. Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy. Angewandte Chemie International Edition. 2024;63(10). doi:10.1002/anie.202318530
BibTeX
@article{Liu2024,
author = {Liu, Jianping and Zhang, Ye and Yang, Bowei and Jia, Yingbo and Liu, Rui-Tian and Ding, Lingwen and Shen, Zheyu and Chen, Xiaoyuan},
title = {Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {10},
doi = {10.1002/anie.202318530}
}
EUVIMED